Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Dublin, Ireland
SEC filing record 1 source field available
Fiscal year end
31 December
Nabriva Therapeutics plc has filed 695 SEC EDGAR filings since 14 May 2015

SEC filing history

Showing 576-600 of 695 matching filings.

Per page
25
Current page
24
4

4

Filing date
01 Jun 2017
Reporting date
30 May 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-37558

8-K

Filing date
31 May 2017
Reporting date
24 May 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
25 May 2017
Reporting date
23 May 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-37558

8-K

Filing date
23 May 2017
Reporting date
23 May 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
425 File 001-37558

8-K

Filing date
23 May 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
425 File 001-37558

425

Filing date
23 May 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
425 File 001-37558

425

Filing date
23 May 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 14D9 File 005-89113

SC 14D9

Filing date
23 May 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC TO-T File 005-89113

SC TO-T

Filing date
23 May 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
17 May 2017
Reporting date
16 Feb 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K/A File 001-37558

8-K/A

Filing date
12 May 2017
Reporting date
10 May 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-37558

8-K

Filing date
10 May 2017
Reporting date
10 May 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 -

Filing date
28 Apr 2017
Reporting date
26 Apr 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 -

Filing date
25 Apr 2017
Reporting date
21 Apr 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 -

Filing date
20 Apr 2017
Reporting date
18 Apr 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-37558

8-K

Filing date
18 Apr 2017
Reporting date
17 Apr 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
425 File 001-37558

8-K

Filing date
18 Apr 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
425 File 001-37558

425

Filing date
18 Apr 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 -

Filing date
13 Apr 2017
Reporting date
11 Apr 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4/A

4/A

Filing date
11 Apr 2017
Reporting date
06 Apr 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 -

Filing date
10 Apr 2017
Reporting date
06 Apr 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-37558

8-K

Filing date
05 Apr 2017
Reporting date
05 Apr 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-37558

8-K

Filing date
24 Mar 2017
Reporting date
24 Mar 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .